STIL

STIL
National Center for Biotechnology Information, U.S. National Library of Medicine · Public domain · source
Name	SCL/TAL1 interrupting locus protein
Organism	Homo sapiens
Gene	STIL
Length	1,315 aa (human isoform)
Location	Chromosome 1p33
Aliases	SIL, TAL1 interrupting locus (TIL)

STIL

Introduction

STIL is a eukaryotic protein encoded by a gene on human chromosome 1p33 with conserved orthologs across metazoans and protozoans. First identified in chromosomal rearrangements associated with hematopoietic malignancies, STIL has been studied in the context of developmental disorders, oncology, and cell-cycle regulation. Research into STIL has connected findings from model organisms including Drosophila melanogaster, Danio rerio, and Mus musculus to clinical observations in human genetics, oncology, and neurodevelopment.

Structure and Function

The STIL polypeptide contains multiple characterized regions including an N-terminal domain implicated in protein–protein interactions, a central serine-rich region subject to phosphorylation, and C-terminal motifs required for centrosomal targeting. Structural studies and proteomic surveys have mapped interaction interfaces between STIL and centriolar components such as SAS-6, as well as regulatory kinases including PLK4 and CDK2. Post-translational modifications of STIL—phosphorylation sites identified in high-throughput phosphoproteomics—modulate binding to the CPAP network and influence stability through ubiquitin ligases like APC/C and SCF complexes. Comparative sequence analysis shows conservation with proteins characterized in Caenorhabditis elegans and Schizosaccharomyces pombe studies that inform on functional motifs and domain architecture.

Role in Cell Cycle and Centriole Duplication

STIL is essential for centriole biogenesis during S phase and for licensing centriole duplication once per cell cycle. It functions as a scaffold enabling recruitment and oligomerization of cartwheel proteins such as SAS-6 at nascent procentriole assembly sites adjacent to existing centrioles marked by CEP192 and CEP152. Regulation by master cell-cycle regulators—interactions with PLK4 trigger STIL phosphorylation and recruitment, while timely degradation is coordinated with APC/C activity to prevent reduplication—ensures fidelity of centrosome number across mitotic cycles. Aberrant STIL function perturbs spindle bipolarity and chromosome segregation, phenotypes also observed in perturbation studies involving Aurora A, BubR1, and Mad2 in mitotic checkpoint contexts. Loss-of-function and overexpression paradigms in Xenopus laevis egg extracts and mammalian cultured cells recapitulate centriole amplification and mitotic defects linked to aneuploidy observed in cancer cell lines such as derived from HeLa and MCF7.

Clinical Significance and Disease Associations

Germline truncating and hypomorphic variants in STIL are causally associated with primary autosomal recessive microcephaly phenotypes identified in clinical genetics cohorts and described alongside other microcephaly genes such as MCPH1, ASPM, and WDR62. Somatic alterations including amplification and translocation events implicate STIL in oncogenesis in hematologic malignancies; historical rearrangements involving the TAL1/SCL locus informed early naming and links to leukemia pathobiology. Overexpression or deregulated stability of STIL correlates with centrosome amplification in solid tumors—observed in studies of breast cancer, colorectal cancer, and glioblastoma—and is investigated as a biomarker for genomic instability and therapeutic response. Neurodevelopmental syndromes featuring microcephaly, intellectual disability, or structural brain anomalies have been reported in patients with STIL mutations evaluated by clinical genetics networks and academic centers such as NIH-supported consortia.

Interactions and Pathways

STIL occupies a nexus connecting centriole assembly machinery and cell-cycle regulatory circuits. Direct and indirect interactions have been reported with SAS-6, CPAP (also known as CENPJ), PLK4, CEP135, and scaffold proteins like CEP152; these interactions facilitate cartwheel formation and centriole elongation. Phospho-regulatory inputs from CDK2 and PLK4 control STIL activity, while ubiquitin-mediated turnover involves E3 ligases such as FBXW5 within SCF complexes; proteasomal regulation integrates with APC/C-driven transitions at mitotic exit. STIL function intersects with centrosome-associated signaling pathways implicated in asymmetric division and neurogenesis studied alongside proteins such as LGL1, Numb, and Par3 in developmental biology paradigms.

Research Tools and Model Systems

Investigation of STIL leverages diverse experimental systems and reagents: gene knockout and conditional alleles in Mus musculus provide in vivo models for microcephaly and tumorigenesis studies; morpholino and CRISPR approaches in Danio rerio and Xenopus tropicalis enable developmental phenotyping; RNAi screens in cultured human cells including U2OS and RPE1 assess centriole dynamics. High-resolution microscopy techniques—electron tomography applied in EMBL-collaborative labs and super-resolution imaging in facilities at institutions like Max Planck Society—map STIL localization relative to centriolar markers. Proteomics platforms, phosphoproteomic workflows from centers such as Broad Institute and interactome mapping initiatives using affinity purification–mass spectrometry elucidate the STIL interactome and post-translational regulation.

Category:Proteins